Trimble (TRMB) fell sharply during regular trading, dropping from $65.61 to $53.96, a -17.76% move on the day. The decline followed Q3 2026 earnings: adjusted EPS of $0.86 and revenue of $966.8 million were in line with estimates, but Q4 revenue guidance of $1.03B–$1.06B came in slightly below consensus, operating margin slipped to 14.7% from 16.7%, and a goodwill impairment drove a nine-month GAAP net loss of $313.7 million.

CVS Health shares fell from a previous close of $91.41 to $81.07 during regular trading, a drop of -11.31%. The decline followed CVS's announcement that it will split into two independent public companies, separating its retail pharmacies from the Aetna and Caremark insurance/PBM businesses, with investors balking at the surprise breakup's multi-year execution risk and regulatory backdrop.

Eastman Kodak (KODK) fell from $8.67 to $8.09, a -6.69% decline, during regular trading on November 4, extending an after-hours slide that followed Tuesday's close. The drop follows Q3 earnings released after the November 3 close: EPS of $0.18 beat the $0.16 consensus, but revenue of $276 million missed the ~$294 million consensus and the Print segment reversed to a 7% decline, with no guidance or analyst Q&A.

CIFR fell during regular market hours, sliding from a prior close of $8.12 to about $6.69, a drop of -17.61%. The decline followed KBW's downgrade of Cipher to Market Perform from Outperform and a price-target cut to $9.50 from $11, after Democrat Gina Hinojosa won the Texas governor's race on a pledge to halt new data-center development, raising regulatory risk for Cipher's Texas-heavy pipeline.

Skyworks Solutions (SWKS) dropped -7.65% during regular trading, sliding from its prior close of $85.40 to $78.87. The decline followed its fiscal Q4 report, where slightly better-than-expected results were overshadowed by weak Q1 guidance (revenue of $1.8B–$1.9B vs. ~$1.99B consensus; EPS of $1.25 vs. ~$1.52), driven by soft premium Android demand and Qorvo integration.

Comfort Systems USA (FIX) dropped -13.40% during regular market hours, sliding from a $1,285.13 prior close to $1,112.96. The decline extends the post-earnings de-rating that began Oct. 22, when blowout Q3 results were overshadowed by margin-pressure concerns, the CFO's retirement, and the absence of 2027 guidance, followed by analyst price-target cuts from UBS, Stifel, KeyBanc, and DA Davidson.

CeriBell (CBLL) fell -2.26%, from a previous close of $28.27 to $27.63, during regular trading on November 4, paring a much steeper early premarket drop. The decline follows Q3 results released after the November 3 close: a wider-than-expected GAAP loss (-$0.55 vs -$0.51 consensus) overshadowed a slight revenue beat ($29.3M) and a raised lower end of 2026 revenue guidance ($115M-$117M), triggering an initial premarket selloff that later faded.

LIME dropped during regular trading, sliding from a prior close of $25.48 to about $19.11, a decline of roughly -25%. After Tuesday's close, Lime posted Q3 EPS of $0.63 and $361M revenue, both above estimates, but cut full-year adjusted EBITDA guidance to $253M–$255M from $265M–$285M and guided Q4 EBITDA of $43M–$45M, well below the ~$58M consensus, as revenue per vehicle fell -4.8% on European competition.

Modine Manufacturing (MOD) dropped from a $125.45 prior close to $99.53, down -20.66%, during regular trading on Nov 4. The slide follows Q2 FY2027 results released after the Nov 3 close: EPS of $1.35 missed the $1.42 estimate, and full-year revenue guidance of $3.10B–$3.20B came in well below the ~$3.54B consensus.

CHOW dropped -18.38% during regular market hours, sliding from a $4.08 prior close to $3.33. No verified news or fundamental catalyst found; the decline is consistent with profit-taking and continued post-reverse-split volatility after the stock's roughly +106% single-session spike on Oct. 30, typical of this thinly traded micro-cap.

FIS stock plunged -22.13%, from a $38.99 prior close to $30.36, with the decline beginning in premarket trading and extending into the regular session. The drop followed in-line Q3 2026 results that came with a sharply reduced full-year outlook: adjusted EPS guidance was cut to $5.82–$5.89 from $6.15–$6.24, alongside lower revenue and EBITDA growth and a suspension of share buybacks.

UNM tumbled from $91.03 to $75.16, down -17.43%, during regular trading on Wednesday. The slide followed Q3 2026 results that swung to a GAAP net loss of $419.7 million (-$2.65/share) on an $853 million investment loss tied to the Fortitude Re long-term-care reinsurance deal, with revenue falling 21.6% to $2.55 billion and elevated group disability claims pressuring margins.

HUT fell from its previous close of $63.75 to about $54.02, a drop of -15.26%, during regular market hours. The catalyst was Q3 2026 earnings: an adjusted EPS loss of -$1.23 (worse than the -$1.06 expected) and revenue of $71.07M, down 14.9% year-over-year and below the $75.8M consensus.

Amdocs (DOX) tumbled from a previous close of $62.43 to $43.49, a -30.34% drop, with the selloff starting in after-hours trading and extending through premarket into Wednesday's regular session. The move followed Q4 FY2026 earnings, where in-line results were overshadowed by far weaker FY2027 guidance — including a 26–30% expected decline in adjusted EPS — driven by a legal dispute with T-Mobile, its second-largest customer, with both sides alleging material contract breaches and threatening termination or arbitration.

Nurix Therapeutics (NRIX) shares plunged from a prior close of $25.82 to $15.24, a drop of -40.98%, with the slide starting in Tuesday's after-hours session and extending into Wednesday's trading. Sanofi notified Nurix it is discontinuing the Phase 1 trial and terminating the entire SAR448272 STAT6 degrader program, eliminating future milestone payments and royalties worth up to roughly $455 million.

TBLA dropped from a previous close of $3.40 to $2.84, a decline of -16.47%, during regular market hours. The drop followed Q3 results: revenue of $462.3M missed the $474.9M consensus, and guidance was cut — Q4 revenue of $477–493M versus roughly $534M expected, with full-year 2026 revenue lowered to $1.88–1.89B, citing impression-volume headwinds and a slower Next Engage rollout.

MTZ dropped -11.15% during regular market hours, sliding from a $198.10 prior close to roughly $176.01 intraday. No verified news or fundamental catalyst found. The move is consistent with profit-taking unwinding the post-earnings bounce in a highly volatile downtrend, with the stock down about 55% from its peak.

WMG rose to $32.05 from the prior session's $31.13 close, up +2.96%, during regular market hours. No verified news or fundamental catalyst found. With fiscal Q4 earnings not due until Nov. 19, the gain likely reflects broad buying consistent with the stock's normal daily range rather than a company-specific driver.

Trimble (TRMB) tumbled from a $65.61 prior close to $53.87, down -17.89%, during regular market hours on November 4. The drop followed Q3 2026 results reported before the open — revenue ($966.8M, +7.3% YoY) and adjusted EPS ($0.86) were in line, but Q4 revenue guidance near $1.05B and a cautious outlook disappointed investors.

EME fell from a previous close of $707.43 to $646.29, a -8.64% decline, during regular market hours. No verified news or fundamental catalyst found; the drop is consistent with profit-taking after the +3.61% post-earnings pop on November 3 and continued rotation out of data-center-exposed construction names on hyperscaler capex durability fears.